In 2016, Valiente et al reported that EPDR1 and its spliced isoforms are differentially expressed in human CRC cell lines, and the up‐regulation of EPDR1 in human colorectal cancer was reported to promote cell growth, proliferation, and invasiveness.28 Here, EPDR1 is linked to colorectal carcinoma.